News & Press Release Distribution Service
FDA identifies trash in vials of drug used to treat enzyme disorders
2009-11-14 21:35:02 (GMT) (Caymanmama.com - Health News News)
Savannah, Georgia (CaymanMama.com) — Health regulators of the Food and Drug Administration have identified small particles of trash and debris from steel, rubber and fiber in drugs made by biotechnology firm Genzyme.
Genzyme is a drug used to treat rare enzyme disorders and the FDA said the particles of trash could cause serious adverse health effects for patients.
Following the FDA’s findings, shares of Genzyme Corp. dipped $3.12, or 5.9 percent, to $50.05 in afternoon trading.
According to the Associated Press, “The FDA announcement is the second case of contamination for the Cambridge, Mass.-based company this year. In June, Genzyme was forced to shut down a key production facility due to viral contamination.”
The other pharmaceuticals affected by the FDA announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen.
The FDA is not removing the drugs from the market on the basis that few alternative treatments exist. It was recommended that physicians closely inspect the vials to Genzyme prior to injecting their patients with the drug.
CaymanMama.com - Press Release Distribution Service
Comments
Articles
- Website design elements that work for your business by Dallas website design company
- Returning to work after the drug rehabilitation process by Canada Drug rehabilitation center
- Drug addiction - Why do drugs influence people?
- Prostate cancer - Things to know
- New York car accident claims - no fault, uninsured or underinsured claims
- Been in a motorcycle accident? Vehicle and Motorcycle accident lawyer educates
- Pakistani youth deprived of recreational facilities
- How to Identify a Brain Injury
- Bluetooth technology: Revolutionized
- Color card printing best for business promotion and personal use
